Acquavella J, Garabrant D, Marsh G, Sorahan T, Weed DL. (2016). Glyphosate epidemiology expert panel review: a weight of evidence systematic review of the relationship between glyphosate exposure and non-Hodgkin’s lymphoma or multiple myeloma. Crit Rev Toxicol. 46(S1). pp. 28–43.
http://dx.doi.org/10.1080/10408444.2016.1214681
When this article was originally published on 28th September 2016, the contributions, contractual status and potential competing interests of all authors and non-author contributors were not fully disclosed. Specifically, the Acknowledgements and Declaration of Interest were not complete. These sections should read as follows:
Acknowledgements
The authors gratefully acknowledge the very useful comments provided by seven reviewers who were selected by the Editor and anonymous to the authors. These comments helped improve the manuscript. William Heydens of Monsanto reviewed the initial draft of our manuscript and commented that the section on analytic selection bias was unclear to him and that we might define the term “grey literature.” He also pointed out some typographical errors. Based on his feedback, the authors decided to clarify the section on analytic selection bias, define grey literature in a footnote, and correct the typos. All additions, deletions, and changes to the draft manuscript were made only by the authors, with unanimous agreement.
Declaration of Interest
The employment affiliation of the authors is as shown on the cover page. However, it should be recognized that each individual participated in the review process and preparation of this paper as an independent professional and not as a representative of their employer. This expert panel evaluation was organized and conducted by Intertek Scientific & Regulatory Consultancy. Funding for this evaluation was provided by Monsanto Company, which is a primary producer of glyphosate and products containing this active ingredient. The authors had sole responsibility for the content of the paper, and the interpretations and opinions expressed in the paper are those of the authors.
JA worked for Monsanto from 1989 through 2004. He is currently a consultant on a legal case unrelated to glyphosate that involves a former Monsanto industrial chemical plant. DG serves on a scientific advisory board to Dow Agro Sciences, which markets pesticides including glyphosate. He was jointly retained by Bayer Corporation; Bayer CropScience LP; Bayer CropScience Holding, Inc.; Dow AgroSciences, L.L.C.; BASF Corporation; Syngenta Crop Protection, Inc., Deere & Company, Lesco, Inc.; and Monsanto in litigation matters concerning glyphosate and leukemia. He also provided consultation in February 2016 to an attorney representing Pharmacia (formerly Monsanto) in litigation that did not involve glyphosate. That consultation consisted of 0.3 hours of professional services, after which he did no further work on the litigation. GM has no additional declarations. TS has received consultancy fees and travel grants from Monsanto Europe SA/NV as a member of the European Glyphosate Toxicology Advisory Panel and participated in the IARC Monograph Meeting for volume 112 which reviewed the literature and provided a carcinogenic hazard assessment for glyphosate as an Observer for the Monsanto Company. In addition, TS has consulted for Monsanto on litigation matters involving glyphosate. DW has consulted on litigation matters concerning Monsanto that did not involve glyphosate. This article is part of a supplement, sponsored and supported by Intertek Scientific & Regulatory Consultancy. Funding for the sponsorship of this supplement was provided to Intertek by the Monsanto Company, which is a primary producer of glyphosate and products containing this active ingredient. JA was paid directly by Monsanto for his work on this expert panel through an existing consultant contract. The other authors (DG, GM, TS, DW) were paid by Intertek, which was funded by Monsanto.
This article is part of a supplement, sponsored and supported by Intertek Scientific & Regulatory Consultancy. Funding for the sponsorship of this supplement was provided to Intertek by the Monsanto Company, which is a primary producer of glyphosate and products containing this active ingredient.
The authors apologize for these errors.